Emerging markets: Models of best practice for the regulatory review of new medicines
5-6th December 2007, Geneva, Switzerland
The CMR International Institute for Regulatory Science returned to Geneva for its second workshop on the regulation of new medicines in the Emerging Markets. A major objective was to identify best practices for the review of new medicines that make the most of limited resources and provide efficient and rapid access to new therapies whilst protecting patient safety.
The Workshop built on the discussions and recommendations from the first Emerging Market Workshop (March 2006) and also took account of related discussions from the Workshop held in October 2006 on the inclusion of Asian countries in Global Drug Development. Amongst a programme of speakers from senior positions in regulatory agencies and industry, the meeting also included collective Round Table discussions which made recommendations and observations on key issues.